Woodline Partners LP Abb Vie Inc. Transaction History

Woodline Partners LP

$14.3 Billion
Q1 2025

A detailed history of Woodline Partners LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Woodline Partners LP holds 628,094 shares of ABBV stock, worth $117 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

628,094

Previous 605,058 3.81%

Holding current value

$117 Million

Previous $108 Million 22.4%

% of portfolio

0.92%

Previous 0.8%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$169.2 - $216.66 $3.9 Million - $4.99 Million	23,036 Added 3.81%	628,094 $132 Million
Q4 2024 Feb 14, 2025	SELL	$164.99 - $203.87 $33.6 Million - $41.5 Million	-203,678 Reduced 25.18%	605,058 $108 Million
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $9.57 Million - $11.6 Million	58,414 Added 7.79%	808,736 $160 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $17.3 Million - $20.2 Million	111,929 Added 17.53%	750,322 $129 Million
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $102 Million - $116 Million	-636,304 Reduced 49.92%	638,393 $116 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $4.31 Million - $4.86 Million	31,351 Added 2.52%	1,274,697 $198 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $110 Million - $127 Million	822,491 Added 195.43%	1,243,346 $185 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $7.84 Million - $9.75 Million	-59,150 Reduced 12.32%	420,855 $56.7 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $4.4 Million - $5.07 Million	30,431 Added 6.77%	480,005 $76.5 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $36.3 Million - $43.5 Million	262,486 Added 140.3%	449,574 $72.7 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $25.1 Million - $28.8 Million	187,088 New	187,088 $25.1 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $141 Million - $175 Million	-1,070,201 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $31.1 Million - $39.4 Million	289,792 Added 37.13%	1,070,201 $145 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $18.1 Million - $20.5 Million	169,879 Added 27.82%	780,409 $84.2 Million
Q2 2021 Aug 16, 2021	BUY	$105.21 - $117.21 $49.4 Million - $55 Million	469,295 Added 332.28%	610,530 $68.8 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $14.4 Million - $15.9 Million	141,235 New	141,235 $15.3 Million

Others Institutions Holding ABBV

# of Institutions

4,264

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $329B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account

Woodline Partners LP Abb Vie Inc. Transaction History